Vogligress 0.3 Tablet

Composition of Vogligress 0.3 Tablet

Vogligress 0.3 Tablet contains Voglibose 0.3 mg. It belongs to the Alpha-glucosidase inhibitor class of medicines.

Uses of Vogligress 0.3 Tablet

Management of type 2 diabetes mellitus to control post-meal (postprandial) blood glucose; used alone or with other antidiabetic medicines along with diet and exercise.

Key benefits

• Reduces post-meal blood sugar spikes
• Improves HbA1c with diet and exercise
• Helps control type 2 diabetes when added to other agents
• Low risk of hypoglycaemia when used alone

How Vogligress 0.3 Tablet works

Voglibose is an alpha-glucosidase inhibitor that delays carbohydrate digestion and absorption in the intestine. This reduces the rise in blood glucose after meals and helps improve overall glycaemic control.

How to take Vogligress 0.3 Tablet

Oral tablet. Usually taken with the first bite of each main meal (as prescribed). Swallow with water; do not crush/chew unless advised. Follow diabetic diet and exercise plan; monitor blood glucose regularly.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.

If you take too much

An overdose of this medicine may cause low blood sugar and marked stomach upset. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Vogligress 0.3 Tablet

Most side effects of Vogligress are mild and settle as the body adjusts. Reported side effects include:

• Flatulence
• abdominal pain
• diarrhoea
• bloating
• nausea

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Vogligress 0.3 Tablet

Warnings and precautions

Not for type 1 diabetes or diabetic ketoacidosis. Use with caution in gastrointestinal disorders (e.g., inflammatory bowel disease, intestinal obstruction, chronic intestinal disease) and in significant liver impairment. Risk of hypoglycaemia increases when combined with insulin or sulfonylureas—if low sugar occurs, treat with glucose/dextrose (not sucrose) because absorption of sucrose is delayed. Consult doctor in elderly and if you have kidney/liver disease.

Do not take Vogligress if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for type 1 diabetes or for diabetic ketoacidosis. Not for people with heart failure, active bladder cancer or unexplained blood in the urine.

Interactions with other medicines

Insulin, sulfonylureas (e.g., glimepiride, gliclazide) may increase hypoglycaemia risk; corticosteroids and thyroid hormones may reduce glycaemic control; intestinal adsorbents/digestive enzymes may reduce effect; other antidiabetic drugs may have additive glucose-lowering effects.

How to store Vogligress 0.3 Tablet

Store at room temperature (below 25°C), protected from moisture and light. Keep in original blister pack and out of reach of children.

Expert advice for Vogligress 0.3 Tablet

Take it with the first mouthful of your meal so it can act on that meal. Expect some wind in the first weeks; it usually settles.

Manufacturer and class

Manufacturer:

LARENON

Therapeutic class:

Antidiabetic

Drug class:

Alpha-glucosidase inhibitor